| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/02/1993 | CA2128701A1 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo¬b|-thiophene-2-carboxamides as inhibitors of cell adhesion |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/02/1993 | CA2107773A1 Hepatoma treatment with somatostatin analogs |
| 09/01/1993 | EP0558449A1 Complexes of chelating ligands and process for their preparation |
| 09/01/1993 | EP0558443A1 O-Piperidyl-(3/4)-hydroxylamines and O-piperidyl-(3/4)-alkyl-hydroxylamines and their use as ornithine decarboxylase inhibitors |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557408A1 Imidazolidinone compounds |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557300A1 Bispecific antibodies, method of production, and uses thereof |
| 09/01/1993 | CN1075722A Steroid, preparing processing, intermediate and application |
| 09/01/1993 | CN1021969C Sialosylcerebrosioles and preparation method thereof |
| 08/31/1993 | US5241084 Protecting 10-hydroxy group by esterification, activating 7-hydroxy group by forming thiocarbonyl ester, deoxygenating, deprotecting |
| 08/31/1993 | US5241051 Secreted by human erythroblastoid cells |
| 08/31/1993 | US5240958 Treating rheumatoid arthritis, promoting wound healing |
| 08/29/1993 | CA2090743A1 Pharmaceutical compounds |
| 08/29/1993 | CA2090097A1 Bu-4641v, an antibacterial, antiviral and antitumor antibiotic |
| 08/28/1993 | CA2090772A1 Chelate complexes and processes for their preparation |
| 08/26/1993 | DE4204922A1 Ketotricyclo(5.2.1.0)decan-derivate Ketotricyclo (5.2.1.0) decane derivatives |
| 08/25/1993 | EP0557075A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents |
| 08/25/1993 | EP0556962A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/25/1993 | EP0556720A1 5-Aminoflavone derivatives |
| 08/25/1993 | EP0556674A1 3,5-substituted benzoylguanidines with antiarrhythmic activity and cell proliferation inhibiting activity |
| 08/25/1993 | EP0556673A1 Ortho-substituted benzoylguanidines for the treatment and prophylaxis of heart-rhythm disorders and ischaemically induced damage, as well as inhibition of cell proliferation |
| 08/25/1993 | EP0556672A1 Amino-substituted benzoylguanidines with antiarrhythmic properties |
| 08/25/1993 | EP0556285A1 Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| 08/25/1993 | CN1021912C Method for the preparation of platinum-(iv)-diamine composite |
| 08/24/1993 | US5239078 Matrix metalloprotease inhibitors |
| 08/24/1993 | US5239075 Process for the preparation of benzo (f) quinolinones |
| 08/24/1993 | US5239074 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
| 08/24/1993 | US5239059 Ion-channel forming peptides |
| 08/24/1993 | US5238936 Antitumor agents, anticarcinogenic agents |
| 08/24/1993 | US5238922 Inhibitors of farnesyl protein transferase |
| 08/24/1993 | CA1321601C 2-chloro-4-((cyanomethyl)thio)phenyl n-methyl carbamate |
| 08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
| 08/24/1993 | CA1321545C Pharmaceutical compositions having antineoplastic activity |
| 08/20/1993 | CA2089974A1 Pharmaceutical compounds |
| 08/19/1993 | WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 08/19/1993 | WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
| 08/19/1993 | WO1993016189A1 Novel macrocyclic lactones and a productive strain thereof |
| 08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | WO1993016068A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 08/19/1993 | WO1993016067A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | WO1993016060A1 Novel baccatine iii and 10-deacetyl baccatine iii derivatives, their preparation, and pharmaceutical compositions containing same |
| 08/19/1993 | WO1993016044A1 Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
| 08/19/1993 | WO1993016040A1 Fluorine-containing vitamin d3 analogues |
| 08/19/1993 | WO1993016029A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | WO1993016026A1 USE OF α-HYDROXYKETOALKYL DERIVATIVES AS PROTECTIVE LIGHT FILTERS |
| 08/19/1993 | WO1993015770A1 Radiolabelled peptide compounds |
| 08/19/1993 | WO1993015740A1 Methods of treating inflammatory dermatoses |
| 08/19/1993 | WO1993015733A1 Reversal of multi-drug resistance by tetraarylethylenes |
| 08/19/1993 | WO1993014070A3 Novel imidazole derivatives, their preparation and therapeutic applications |
| 08/19/1993 | WO1993013779A3 Use of udpg as cancer therapy rescue agent |
| 08/19/1993 | DE4304236A1 Use of new and known alpha-hydroxy:keto:alkyl derivs. - as light filters, e.g. for protection of skin and hair |
| 08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | CA2129973A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 08/19/1993 | CA2129831A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | CA2129830A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | CA2129114A1 Methods of treating inflammatory dermatoses |
| 08/19/1993 | CA2129033A1 Radiolabelled peptide compounds |
| 08/19/1993 | CA2128529A1 Novel macrocyclic lactones and a productive strain thereof |
| 08/19/1993 | CA2127372A1 Novel derivatives of baccatin iii and of 10-deacetyl baccatin iii, their preparation and pharmaceutical compositions containing them |
| 08/19/1993 | CA2106854A1 Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same |
| 08/18/1993 | EP0556092A1 1,4-Dihydropyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1993 | EP0555898A2 Medicaments for non-topical use |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555352A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
| 08/18/1993 | EP0555286A1 Cell growth inhibitors |
| 08/18/1993 | EP0555235A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 08/18/1993 | CA2089533A1 Derivatives of saturated nitrogen heterocycles |
| 08/17/1993 | US5237110 19-nor-vitamin d compounds |
| 08/17/1993 | US5237061 17B-substituted 3-oxo-4-azasteroids, imidazolide intermediate |
| 08/17/1993 | US5236927 Reduced toxicity; side effect reduction |
| 08/17/1993 | US5236914 Derivatives of metalloporphyrins and application thereof for therapeutic purposes and in preparing hybrid molecules |
| 08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
| 08/17/1993 | US5236706 Pharmaceutical preparation for the maturation of prothymocytes |
| 08/17/1993 | CA1321389C Antitumor alkaloids |
| 08/17/1993 | CA1321363C Application of oligonucleotides linked to an intercalating agent, especially as a drug |
| 08/17/1993 | CA1321349C Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
| 08/17/1993 | CA1321348C Treatment of certain leukemias with a combination of gamma interferon and alpha interferon |
| 08/14/1993 | WO1993016024A1 Novel antitumor compound, compositions and method of use |
| 08/14/1993 | CA2129956A1 Novel antitumor compound, compositions and method of use |
| 08/12/1993 | CA2089247A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/11/1993 | EP0555036A2 Antitumor compositions and methods of treatment |
| 08/11/1993 | EP0554708A1 Thioether conjugates |
| 08/11/1993 | EP0554445A1 Antineoplastic drug of plant extraction and process for the preparation thereof |
| 08/11/1993 | EP0554358A1 Chelating agents |
| 08/11/1993 | EP0554356A1 A monoclonal antibody |
| 08/11/1993 | EP0554344A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 08/11/1993 | EP0447491B1 Protoporphyrinogen inhibitors and their use in compositions for detecting and treating tumours |
| 08/11/1993 | CA2088744A1 Method for treating cancer using a tyrosine protein kinase inhibitor |
| 08/10/1993 | US5235076 Anticarcinogenic agents |
| 08/10/1993 | US5234955 Antitumor compositions and methods of treatment |
| 08/10/1993 | CA2042053C Lipid a monosaccharide analogues |
| 08/10/1993 | CA1321204C Acylation products of bis(2-imidazolin-2- ylhydrazones) of 9,10-anthracenedicarboxaldehyde |
| 08/10/1993 | CA1321196C Antiviral tricyclic benzocyclopyrimidine derivatives |
| 08/10/1993 | CA1321145C Pharmaceutical preparations |
| 08/10/1993 | CA1321144C Pharmaceutical preparations |
| 08/07/1993 | WO1993015754A1 Hepatic growth factor receptor |
| 08/07/1993 | CA2129423A1 Hepatic growth factor receptor |